Recent studies have shown that CRP, a traditional nonspecific acute phase protein produced by the liver that upregulates NF-kB activity and contributes to pathways that interfere with insulin signalling, is one of the inflammatory cytokines associated with NAFLD (37–39). This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatotic liver disease.